BIOCHEMICAL ASPECTS OF THE PHARMACOLOGY OF MOCLOBEMIDE - THE IMPLICATIONS OF ANIMAL STUDIES

被引：9

作者：

CALLINGHAM, BA

机构：

来源：

关键词：

D O I：

10.1192/S0007125000297493

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：53 / 60

页数：8

共 49 条

[21] DAPRADA M, 1989, J PHARMACOL EXP THER, V248, P400
[22] DAPRADA M, 1984, MONAOMINE OXIDASE DI
[23] DAPRADA M, 1986, ADV NNEUROLOGY, V45
[24] DAPRADA M, 1982, MONOAMINE OXIDASE BA
[25] DELLACORTE L, 1977, BIOCHEM PHARMACOL, V26, P407
[26] DELLACORTE L, 1980, BIOCHEM PHARMACOL, V29, P811
[27] Finberg J P, 1988, J Neural Transm Suppl, V26, P11
[28] TYRAMINE ANTAGONISTIC PROPERTIES OF AGN-1135, AN IRREVERSIBLE INHIBITOR OF MONOAMINE-OXIDASE TYPE-B
FINBERG, JPM
TENNE, M
YOUDIM, MBH
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1981, 73 (01) : 65 - 74
[29] RELATIONSHIP BETWEEN TYRAMINE POTENTIATION AND SELECTIVE-INHIBITION OF MONOAMINE-OXIDASE TYPE-A AND TYPE-B IN THE RAT VAS-DEFERENS
FINBERG, JPM
TENNE, M
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1982, 77 (01) : 13 - 21
[30] MONOAMINE-OXIDASE A AND B - USEFUL CONCEPT
FOWLER, CJ
CALLINGHAM, BA
MANTLE, TJ
TIPTON, KF
[J]. BIOCHEMICAL PHARMACOLOGY, 1978, 27 (01) : 97 - 101